Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.311936310607806e-44,285.07795100222717,28804.914728520536,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.555347401747154e-42,0,0,64
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.2652197625170216e-29,96.10576923076923,6394.851154182137,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5', 'SLC25A6']",1.7143727782105644e-27,0,0,45
3,Nonalcoholic fatty liver disease WP4396,4.619654444797911e-21,23.4376130198915,1097.4420196821031,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",4.1730878484674465e-19,0,0,39
4,Oxidative phosphorylation WP623,1.239913553871808e-13,31.261224489795918,929.0387177981041,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",8.4004143274815e-12,0,0,23
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.7060020033467945e-11,36.345454545454544,872.9626586663908,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",2.0086530858139628e-09,0,0,18
6,Mitochondrial CIV Assembly WP4922,4.88565874299856e-10,60.24096385542169,1291.5389640592737,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",2.206689198921016e-08,0,0,15
7,Mitochondrial complex III assembly WP4921,2.877426933479551e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.00011139752842470833,0,0,8
8,Cholesterol Biosynthesis Pathway WP197,0.0004081387292359915,23.668639053254438,184.70777322408225,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.012289510624772633,0,0,6
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0004081387292359915,23.668639053254438,184.70777322408225,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.012289510624772633,0,0,6
10,Selenium Micronutrient Network WP15,0.0006393470330770668,4.849933598937583,35.67156795774455,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH', 'SOD1', 'MSRB1']",0.01732630459638851,0,0,11
11,Eukaryotic Transcription Initiation WP405,0.0017373405031129896,19.68503937007874,125.10629491158288,"['TAF13', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.04280175239487456,0,0,5
12,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.003356083001828137,7.881656804733728,44.90164716020802,"['IDI1', 'SQLE', 'HMGCS1', 'HMGCR', 'LDLR', 'FDFT1']",0.07579154112461876,0,0,6
13,Statin inhibition of cholesterol production WP430,0.007195202369025911,15.717092337917485,77.55349017991368,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.13481756579320256,0,0,4
14,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.008457190474112338,inf,inf,"['HMGCS1', 'HMGCR', 'LDLR']",0.13481756579320256,0,0,3
15,Cellular Proteostasis WP4918,0.008457190474112338,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.13481756579320256,0,0,3
16,Histone Modifications WP2369,0.008457190474112338,inf,inf,"['SET', 'H3F3B', 'H3F3A']",0.13481756579320256,0,0,3
17,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.008457190474112338,inf,inf,"['IDI1', 'HMGCS1', 'HMGCR']",0.13481756579320256,0,0,3
18,Pyrimidine metabolism WP4022,0.012084356044779141,3.5062706270627064,15.483142539179171,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.18193669378528596,0,0,8
19,Nanomaterial induced apoptosis WP2507,0.018110962178475104,7.854616895874264,31.506736816348734,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.25831951317719754,0,0,4
20,Androgen receptor signaling pathway WP138,0.01977470911419874,3.446393280632411,13.521412161728659,"['KAT5', 'PRDX1', 'BAG1', 'STUB1', 'PARK7', 'CALR', 'FKBP4']",0.2679473084973929,0,0,7
21,mRNA Processing WP411,0.02110154460054009,4.9138779527559056,18.959751101408838,"['SF3B5', 'LSM7', 'SNRPE', 'SNU13', 'SRSF9']",0.27231040889268404,0,0,5
22,7q11.23 copy number variation syndrome WP4932,0.025615095188898315,2.865886588658866,10.502251890496249,"['ATP5F1B', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.30181264331267144,0,0,8
23,Integrated breast cancer pathway WP1984,0.025615095188898315,2.865886588658866,10.502251890496249,"['GADD45A', 'TRADD', 'ODC1', 'BAX', 'PHB', 'FADD', 'HMGCR', 'FAU']",0.30181264331267144,0,0,8
24,Vitamin B12 metabolism WP1533,0.028675745510257148,11.764705882352942,41.784748443419254,"['CUBN', 'LDLR', 'SOD1']",0.32379695971998695,0,0,3
25,Synaptic Vesicle Pathway WP2267,0.035248361783883346,3.9291338582677167,13.144273829015177,"['SLC32A1', 'PARK7', 'AP2M1', 'VAMP2', 'CPLX3']",0.3437034740663736,0,0,5
26,Copper homeostasis WP3286,0.035511798058518305,5.233791748526523,17.469822699351703,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.3437034740663736,0,0,4
27,Folate Metabolism WP176,0.035511798058518305,5.233791748526523,17.469822699351703,"['AHCY', 'GPX4', 'LDLR', 'SOD1']",0.3437034740663736,0,0,4
28,Genotoxicity pathway WP4286,0.035511798058518305,5.233791748526523,17.469822699351703,"['RPS27', 'GADD45A', 'TRIAP1', 'PHLDA3']",0.3437034740663736,0,0,4
29,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.041574541620585576,inf,inf,"['COX8A', 'GSTP1']",0.36344196061866746,0,0,2
30,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.041574541620585576,inf,inf,"['H3F3B', 'H3F3A']",0.36344196061866746,0,0,2
31,SARS-CoV-2 mitochondrial interactions WP5038,0.041574541620585576,inf,inf,"['NDUFB9', 'PHB']",0.36344196061866746,0,0,2
32,Proteasome Degradation WP183,0.05404300795602509,3.2726377952755907,9.549475616851197,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.44734081373446405,0,0,5
33,VEGFA-VEGFR2 Signaling Pathway WP3888,0.05447323562080189,1.616094713747568,4.702909613883083,"['SET', 'SDF2L1', 'SSR4', 'TRPC3', 'RPL13A', 'RPL10A', 'RPL7', 'DNAJA1', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'SH3BGRL3', 'RPL26', 'FADD', 'CALR', 'CCT7', 'HRAS']",0.44734081373446405,0,0,20
34,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.06089661478832946,5.879411764705883,16.453990608021723,"['H3F3B', 'H2AFZ', 'H3F3A']",0.4715137887896367,0,0,3
35,p38 MAPK Signaling Pathway WP400,0.06089661478832946,5.879411764705883,16.453990608021723,"['TRADD', 'DDIT3', 'HRAS']",0.4715137887896367,0,0,3
36,Cytosolic DNA-sensing pathway WP4655,0.07758326348878201,2.803712035995501,7.167419406890448,"['TRADD', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.5840295668183313,0,0,5
37,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.09072402297022798,3.13713163064833,7.528906024002607,"['PPP1CC', 'PPP1R14B', 'XBP1', 'DDIT3']",0.6351374994952808,0,0,4
38,Glycolysis in senescence WP5049,0.10368230677648999,3.9176470588235293,8.879048524809468,"['LDHA', 'PKM', 'ALDOC']",0.6351374994952808,0,0,3
39,Photodynamic therapy-induced unfolded protein response WP3613,0.10368230677648999,3.9176470588235293,8.879048524809468,"['XBP1', 'DDIT3', 'CALR']",0.6351374994952808,0,0,3
40,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.10368230677648999,3.9176470588235293,8.879048524809468,"['CXCL12', 'TRADD', 'FADD']",0.6351374994952808,0,0,3
41,Amyotrophic lateral sclerosis (ALS) WP2447,0.10780931725750152,7.8277886497064575,17.435547501229394,"['BAX', 'SOD1']",0.6351374994952808,0,0,2
42,TP53 network WP1742,0.10780931725750152,7.8277886497064575,17.435547501229394,"['GADD45A', 'BAX']",0.6351374994952808,0,0,2
43,Vitamin D-sensitive calcium signaling in depression WP4698,0.10780931725750152,7.8277886497064575,17.435547501229394,"['CALB1', 'GPX4']",0.6351374994952808,0,0,2
44,EV release from cardiac cells and their functional effects WP3297,0.10780931725750152,7.8277886497064575,17.435547501229394,"['CXCL12', 'RGS16']",0.6351374994952808,0,0,2
45,Mevalonate pathway WP3963,0.10780931725750152,7.8277886497064575,17.435547501229394,"['HMGCS1', 'HMGCR']",0.6351374994952808,0,0,2
46,Nanoparticle triggered regulated necrosis WP2513,0.10780931725750152,7.8277886497064575,17.435547501229394,"['TRADD', 'FADD']",0.6351374994952808,0,0,2
47,Apoptosis WP254,0.12770781731516395,2.612966601178782,5.377512182876383,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.7063024182124373,0,0,4
48,Melanoma WP4685,0.12770781731516395,2.612966601178782,5.377512182876383,"['GADD45A', 'BAX', 'CALM3', 'HRAS']",0.7063024182124373,0,0,4
49,Non-small cell lung cancer WP4255,0.12770781731516395,2.612966601178782,5.377512182876383,"['GADD45A', 'CYCS', 'BAX', 'HRAS']",0.7063024182124373,0,0,4
50,Apoptosis Modulation and Signaling WP1772,0.13811613182455684,2.1784776902887137,4.312646043537548,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.7485894344890981,0,0,5
51,Ciliary landscape WP4352,0.14227439201088213,1.9615384615384615,3.82499558230106,"['PSMD8', 'EXOSC4', 'H3F3A', 'COPS7A', 'COX6C', 'LSM4']",0.7560070634303736,0,0,6
52,Amino Acid metabolism WP3925,0.1548102126271698,2.9367647058823527,5.478697099819015,"['LDHA', 'PKM', 'ODC1']",0.7698945440381899,0,0,3
53,Leptin signaling pathway WP2034,0.1548102126271698,2.9367647058823527,5.478697099819015,"['CFL2', 'BAX', 'HRAS']",0.7698945440381899,0,0,3
54,Parkinson's disease pathway WP2371,0.1548102126271698,2.9367647058823527,5.478697099819015,"['PINK1', 'CYCS', 'PARK7']",0.7698945440381899,0,0,3
55,Translation Factors WP107,0.16980200718150495,2.2385630087005333,3.969245731720197,"['EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H']",0.7698945440381899,0,0,4
56,Target Of Rapamycin (TOR) Signaling WP1471,0.18694291934973695,3.911937377690802,6.5601310249184,"['IDI1', 'HMGCR']",0.7698945440381899,0,0,2
57,Tumor suppressor activity of SMARCB1 WP4204,0.18694291934973695,3.911937377690802,6.5601310249184,"['H3F3B', 'H3F3A']",0.7698945440381899,0,0,2
58,GABA receptor Signaling WP4159,0.18694291934973695,3.911937377690802,6.5601310249184,"['SLC32A1', 'AP2M1']",0.7698945440381899,0,0,2
59,Methionine De Novo and Salvage Pathway WP3580,0.18694291934973695,3.911937377690802,6.5601310249184,"['AHCY', 'ODC1']",0.7698945440381899,0,0,2
60,Nucleotide metabolism WP404,0.18694291934973695,3.911937377690802,6.5601310249184,"['NME2', 'OAZ1']",0.7698945440381899,0,0,2
61,Oxidative Stress WP408,0.18694291934973695,3.911937377690802,6.5601310249184,"['TXN2', 'SOD1']",0.7698945440381899,0,0,2
62,15q11.2 copy number variation syndrome WP4940,0.2040570334480096,inf,inf,['TUBGCP4'],0.7698945440381899,0,0,1
63,Vitamin B12 Disorders WP4271,0.2040570334480096,inf,inf,['CUBN'],0.7698945440381899,0,0,1
64,Composition of Lipid Particles WP3601,0.2040570334480096,inf,inf,['LDLR'],0.7698945440381899,0,0,1
65,Energy Metabolism WP1541,0.2040570334480096,inf,inf,['UCP3'],0.7698945440381899,0,0,1
66,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.2040570334480096,inf,inf,['MAFF'],0.7698945440381899,0,0,1
67,Glycerophospholipid Biosynthetic Pathway WP2533,0.2040570334480096,inf,inf,['CDIPT'],0.7698945440381899,0,0,1
68,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2040570334480096,inf,inf,['ELOB'],0.7698945440381899,0,0,1
69,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.2040570334480096,inf,inf,['HRAS'],0.7698945440381899,0,0,1
70,Mitochondrial CII Assembly WP4920,0.2040570334480096,inf,inf,['SDHAF1'],0.7698945440381899,0,0,1
71,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2040570334480096,inf,inf,['LDHA'],0.7698945440381899,0,0,1
72,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.2118279403640543,2.348235294117647,3.6444164094633935,"['CXCL12', 'TRADD', 'FADD']",0.7698945440381899,0,0,3
73,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2118279403640543,2.348235294117647,3.6444164094633935,"['LDHA', 'PKM', 'BAX']",0.7698945440381899,0,0,3
74,Alzheimer's disease WP2059,0.2159113850439204,1.9577603143418467,3.0010257459076253,"['ATP5MD', 'CYCS', 'CALM3', 'FADD']",0.7698945440381899,0,0,4
75,TNF-alpha signaling pathway WP231,0.2159113850439204,1.9577603143418467,3.0010257459076253,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.7698945440381899,0,0,4
76,Glycolysis and Gluconeogenesis WP534,0.2159113850439204,1.9577603143418467,3.0010257459076253,"['LDHA', 'PKM', 'PGAM1', 'ALDOC']",0.7698945440381899,0,0,4
77,IL-18 signaling pathway WP4754,0.24857454888417552,1.3482943227091633,1.8768425278685332,"['ARL4D', 'IMP3', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'RND2', 'ITM2C']",0.8573571769568525,0,0,11
78,16p11.2 proximal deletion syndrome WP4949,0.2648834099668993,1.739358218729535,2.310677406938285,"['TCP1', 'SEZ6L2', 'CCT7', 'CDIPT']",0.8573571769568525,0,0,4
79,Apoptosis Modulation by HSP70 WP384,0.27097379003729855,2.6066536203522506,3.403594116975135,"['CYCS', 'FADD']",0.8573571769568525,0,0,2
80,BDNF-TrkB Signaling WP3676,0.27097379003729855,2.6066536203522506,3.403594116975135,"['TRPC3', 'HRAS']",0.8573571769568525,0,0,2
81,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.27097379003729855,2.6066536203522506,3.403594116975135,"['BANF1', 'HRAS']",0.8573571769568525,0,0,2
82,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.27097379003729855,2.6066536203522506,3.403594116975135,"['BAX', 'FADD']",0.8573571769568525,0,0,2
83,p53 transcriptional gene network WP4963,0.27097379003729855,2.6066536203522506,3.403594116975135,"['GADD45A', 'BAX']",0.8573571769568525,0,0,2
84,Ferroptosis WP4313,0.2723798982013832,1.9558823529411764,2.5437374682792857,"['MAP1LC3B', 'GPX4', 'VDAC2']",0.8573571769568525,0,0,3
85,Metabolic reprogramming in colon cancer WP4290,0.2723798982013832,1.9558823529411764,2.5437374682792857,"['LDHA', 'PKM', 'PGAM1']",0.8573571769568525,0,0,3
86,Exercise-induced Circadian Regulation WP410,0.31559031456301334,1.5646365422396857,1.8045115642242304,"['DNAJA1', 'IDI1', 'GSTP1', 'UCP3']",0.8573571769568525,0,0,4
87,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3343822081288079,1.6756302521008404,1.8356036852602535,"['GADD45A', 'CYCS', 'BAX']",0.8573571769568525,0,0,3
88,Endometrial cancer WP4155,0.3343822081288079,1.6756302521008404,1.8356036852602535,"['GADD45A', 'BAX', 'HRAS']",0.8573571769568525,0,0,3
89,Sleep regulation WP3591,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['AHCY', 'CRH']",0.8573571769568525,0,0,2
90,Unfolded protein response WP4925,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['XBP1', 'DDIT3']",0.8573571769568525,0,0,2
91,Cori Cycle WP1946,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['LDHA', 'PGAM1']",0.8573571769568525,0,0,2
92,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['CD63', 'SOD1']",0.8573571769568525,0,0,2
93,MET in type 1 papillary renal cell carcinoma WP4205,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['RPL11', 'HRAS']",0.8573571769568525,0,0,2
94,One-carbon metabolism and related pathways WP3940,0.35461951332579944,1.9540117416829745,2.0257432347356192,"['GPX4', 'SOD1']",0.8573571769568525,0,0,2
95,Serotonin and anxiety WP3947,0.3665394200570192,3.90625,3.9205047082145095,['CRH'],0.8573571769568525,0,0,1
96,Serotonin and anxiety-related events WP3944,0.3665394200570192,3.90625,3.9205047082145095,['CRH'],0.8573571769568525,0,0,1
97,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
98,Autophagy WP4923,0.3665394200570192,3.90625,3.9205047082145095,['MAP1LC3B'],0.8573571769568525,0,0,1
99,Trans-sulfuration and one-carbon metabolism WP2525,0.3665394200570192,3.90625,3.9205047082145095,['AHCY'],0.8573571769568525,0,0,1
100,Transcriptional cascade regulating adipogenesis WP4211,0.3665394200570192,3.90625,3.9205047082145095,['DDIT3'],0.8573571769568525,0,0,1
101,Cysteine and methionine catabolism WP4504,0.3665394200570192,3.90625,3.9205047082145095,['AHCY'],0.8573571769568525,0,0,1
102,Dopamine metabolism WP2436,0.3665394200570192,3.90625,3.9205047082145095,['SOD1'],0.8573571769568525,0,0,1
103,Glycerolipids and Glycerophospholipids WP4722,0.3665394200570192,3.90625,3.9205047082145095,['CDIPT'],0.8573571769568525,0,0,1
104,IL-2 signaling pathway WP49,0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
105,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3665394200570192,3.90625,3.9205047082145095,['BAX'],0.8573571769568525,0,0,1
106,MAPK Cascade WP422,0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
107,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3665394200570192,3.90625,3.9205047082145095,['AHCY'],0.8573571769568525,0,0,1
108,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3665394200570192,3.90625,3.9205047082145095,['BAX'],0.8573571769568525,0,0,1
109,MTHFR deficiency WP4288,0.3665394200570192,3.90625,3.9205047082145095,['CYCS'],0.8573571769568525,0,0,1
110,Overview of nanoparticle effects WP3287,0.3665394200570192,3.90625,3.9205047082145095,['BAX'],0.8573571769568525,0,0,1
111,PDGFR-beta pathway WP3972,0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
112,Peroxiredoxin 2 induced ovarian failure WP4873,0.3665394200570192,3.90625,3.9205047082145095,['BAX'],0.8573571769568525,0,0,1
113,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3665394200570192,3.90625,3.9205047082145095,['TRPC3'],0.8573571769568525,0,0,1
114,RalA downstream regulated genes WP2290,0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
115,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3665394200570192,3.90625,3.9205047082145095,['HRAS'],0.8573571769568525,0,0,1
116,Hepatitis B infection WP4666,0.3669868358929701,1.4216824432934452,1.42513613797746,"['CYCS', 'BAX', 'FADD', 'HRAS']",0.8573571769568525,0,0,4
117,DNA damage response WP707,0.39609976517951545,1.4654411764705881,1.357129198677365,"['GADD45A', 'CYCS', 'BAX']",0.9096867488444804,0,0,3
118,miRNA regulation of DNA damage response WP1530,0.39609976517951545,1.4654411764705881,1.357129198677365,"['GADD45A', 'CYCS', 'BAX']",0.9096867488444804,0,0,3
119,Senescence and Autophagy in Cancer WP615,0.43264901343556417,1.2210875984251968,1.0230619570292412,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'HRAS', 'GABARAP']",0.914218285078237,0,0,5
120,Computational Model of Aerobic Glycolysis WP4629,0.43454320250349376,1.562426614481409,1.3022199436620157,"['LDHA', 'PKM']",0.914218285078237,0,0,2
121,DNA IR-double strand breaks and cellular response via ATM WP3959,0.43454320250349376,1.562426614481409,1.3022199436620157,"['KAT5', 'BAX']",0.914218285078237,0,0,2
122,Acute viral myocarditis WP4298,0.45616253388674566,1.3019607843137255,1.0219169602837013,"['ENDOG', 'CYCS', 'BAX']",0.914218285078237,0,0,3
123,DNA damage response (only ATM dependent) WP710,0.45616253388674566,1.3019607843137255,1.0219169602837013,"['BAX', 'HRAS', 'LDLR']",0.914218285078237,0,0,3
124,Signaling of Hepatocyte Growth Factor Receptor WP313,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
125,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
126,Trans-sulfuration pathway WP2333,0.49590438341882226,1.9521484375,1.369182539322155,['AHCY'],0.914218285078237,0,0,1
127,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.49590438341882226,1.9521484375,1.369182539322155,['VIP'],0.914218285078237,0,0,1
128,Dual hijack model of Vif in HIV infection WP3300,0.49590438341882226,1.9521484375,1.369182539322155,['ELOB'],0.914218285078237,0,0,1
129,Ebstein-Barr virus LMP1 signaling WP262,0.49590438341882226,1.9521484375,1.369182539322155,['TRADD'],0.914218285078237,0,0,1
130,Ethanol effects on histone modifications WP3996,0.49590438341882226,1.9521484375,1.369182539322155,['AHCY'],0.914218285078237,0,0,1
131,Fatty acid transporters WP5061,0.49590438341882226,1.9521484375,1.369182539322155,['FABP6'],0.914218285078237,0,0,1
132,Gastric acid production WP2596,0.49590438341882226,1.9521484375,1.369182539322155,['VIP'],0.914218285078237,0,0,1
133,Gastric Cancer Network 1 WP2361,0.49590438341882226,1.9521484375,1.369182539322155,['H3F3A'],0.914218285078237,0,0,1
134,Genes targeted by miRNAs in adipocytes WP1992,0.49590438341882226,1.9521484375,1.369182539322155,['TMSB4X'],0.914218285078237,0,0,1
135,Glutathione metabolism WP100,0.49590438341882226,1.9521484375,1.369182539322155,['GPX4'],0.914218285078237,0,0,1
136,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.49590438341882226,1.9521484375,1.369182539322155,['LDHA'],0.914218285078237,0,0,1
137,HIF1A and PPARG regulation of glycolysis WP2456,0.49590438341882226,1.9521484375,1.369182539322155,['LDHA'],0.914218285078237,0,0,1
138,Interleukin-11 Signaling Pathway WP2332,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
139,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
140,Kit receptor signaling pathway WP304,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
141,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.49590438341882226,1.9521484375,1.369182539322155,['LDLR'],0.914218285078237,0,0,1
142,Nanoparticle-mediated activation of receptor signaling WP2643,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
143,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.49590438341882226,1.9521484375,1.369182539322155,['EIF3I'],0.914218285078237,0,0,1
144,One-carbon metabolism WP241,0.49590438341882226,1.9521484375,1.369182539322155,['AHCY'],0.914218285078237,0,0,1
145,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.49590438341882226,1.9521484375,1.369182539322155,['HRAS'],0.914218285078237,0,0,1
146,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.49590438341882226,1.9521484375,1.369182539322155,['BAX'],0.914218285078237,0,0,1
147,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.49590438341882226,1.9521484375,1.369182539322155,['CALM3'],0.914218285078237,0,0,1
148,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5087815834469391,1.3013698630136987,0.8793830691555051,"['HRAS', 'MYL12B']",0.9253678464034932,0,0,2
149,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5087815834469391,1.3013698630136987,0.8793830691555051,"['IFI27L2', 'HRAS']",0.9253678464034932,0,0,2
150,Pathways in clear cell renal cell carcinoma WP4018,0.5135462412423435,1.1711764705882353,0.7804898048841081,"['LDHA', 'PKM', 'ALDOC']",0.9260978414502453,0,0,3
151,Circadian rhythm related genes WP3594,0.5605146269997576,1.0267302113551595,0.5943740582305143,"['PPP1CC', 'AHCY', 'CRH', 'RPS27A', 'UBA52']",0.9260978414502453,0,0,5
152,AGE/RAGE pathway WP2324,0.5763248761801071,1.114900754822477,0.6144036956913039,"['CYCS', 'SOD1']",0.9260978414502453,0,0,2
153,Base Excision Repair WP4752,0.5763248761801071,1.114900754822477,0.6144036956913039,"['NEIL2', 'POLE3']",0.9260978414502453,0,0,2
154,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5763248761801071,1.114900754822477,0.6144036956913039,"['CYCS', 'FADD']",0.9260978414502453,0,0,2
155,Head and Neck Squamous Cell Carcinoma WP4674,0.5763248761801071,1.114900754822477,0.6144036956913039,"['FADD', 'HRAS']",0.9260978414502453,0,0,2
156,Hippo-Merlin Signaling Dysregulation WP4541,0.5763248761801071,1.114900754822477,0.6144036956913039,"['PPP1CC', 'HRAS']",0.9260978414502453,0,0,2
157,Modulators of TCR signaling and T cell activation WP5072,0.5763248761801071,1.114900754822477,0.6144036956913039,"['NDUFB10', 'ELOB']",0.9260978414502453,0,0,2
158,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5763248761801071,1.114900754822477,0.6144036956913039,"['BAX', 'HRAS']",0.9260978414502453,0,0,2
159,Bile acids synthesis and enterohepatic circulation  WP4389,0.5988914538985125,1.30078125,0.6668779095932095,['LDLR'],0.9260978414502453,0,0,1
160,CAMKK2  Pathway WP4874,0.5988914538985125,1.30078125,0.6668779095932095,['FIS1'],0.9260978414502453,0,0,1
161,White fat cell differentiation WP4149,0.5988914538985125,1.30078125,0.6668779095932095,['DDIT3'],0.9260978414502453,0,0,1
162,ERK Pathway in Huntington's Disease WP3853,0.5988914538985125,1.30078125,0.6668779095932095,['HRAS'],0.9260978414502453,0,0,1
163,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5988914538985125,1.30078125,0.6668779095932095,['HRAS'],0.9260978414502453,0,0,1
164,Glycosylation and related congenital defects WP4521,0.5988914538985125,1.30078125,0.6668779095932095,['DPM3'],0.9260978414502453,0,0,1
165,IL-1 signaling pathway WP195,0.5988914538985125,1.30078125,0.6668779095932095,['HSPB2'],0.9260978414502453,0,0,1
166,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5988914538985125,1.30078125,0.6668779095932095,['VEGFB'],0.9260978414502453,0,0,1
167,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5988914538985125,1.30078125,0.6668779095932095,['SCO2'],0.9260978414502453,0,0,1
168,Neovascularisation processes WP4331,0.5988914538985125,1.30078125,0.6668779095932095,['CXCL12'],0.9260978414502453,0,0,1
169,Osteoclast Signaling WP12,0.5988914538985125,1.30078125,0.6668779095932095,['ATP6V1G1'],0.9260978414502453,0,0,1
170,PDGF Pathway WP2526,0.5988914538985125,1.30078125,0.6668779095932095,['HRAS'],0.9260978414502453,0,0,1
171,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5988914538985125,1.30078125,0.6668779095932095,['BAX'],0.9260978414502453,0,0,1
172,Regulation of Microtubule Cytoskeleton WP2038,0.5988914538985125,1.30078125,0.6668779095932095,['CFL2'],0.9260978414502453,0,0,1
173,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5988914538985125,1.30078125,0.6668779095932095,['ANAPC11'],0.9260978414502453,0,0,1
174,Myometrial relaxation and contraction pathways WP289,0.5998603461252562,0.9749015748031497,0.4982316461086461,"['RGS16', 'MAFF', 'CRH', 'CALM3', 'IGFBP6']",0.9260978414502453,0,0,5
175,Complement system WP2806,0.6176709874613404,0.975,0.4697543623881225,"['RPS19', 'CD59', 'CALR']",0.9260978414502453,0,0,3
176,DNA Repair Pathways Full Network WP4946,0.6176709874613404,0.975,0.4697543623881225,"['NEIL2', 'CENPX', 'POLE3']",0.9260978414502453,0,0,3
177,22q11.2 copy number variation syndrome WP4657,0.6368104928850826,0.9750489236790607,0.4400231663233241,"['RANBP1', 'MRPL40']",0.9260978414502453,0,0,2
178,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6368104928850826,0.9750489236790607,0.4400231663233241,"['TMSB4X', 'SOD1']",0.9260978414502453,0,0,2
179,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6368104928850826,0.9750489236790607,0.4400231663233241,"['BAX', 'HRAS']",0.9260978414502453,0,0,2
180,Oncostatin M Signaling Pathway WP2374,0.6368104928850826,0.9750489236790607,0.4400231663233241,"['HRAS', 'LDLR']",0.9260978414502453,0,0,2
181,EGF/EGFR signaling pathway WP437,0.6637149812523695,0.8995475113122172,0.36872674385434295,"['NDUFA13', 'HRAS', 'AP2M1']",0.9260978414502453,0,0,3
182,Insulin Signaling WP481,0.6637149812523695,0.8995475113122172,0.36872674385434295,"['XBP1', 'HRAS', 'VAMP2']",0.9260978414502453,0,0,3
183,Proximal tubule transport WP4917,0.6637149812523695,0.8995475113122172,0.36872674385434295,"['ATP6V1G1', 'SLC13A3', 'ATP6V1F']",0.9260978414502453,0,0,3
184,7-oxo-C and 7beta-HC pathways WP5064,0.6808707863293184,0.97509765625,0.37481070098713887,['ACOT11'],0.9260978414502453,0,0,1
185,ATM Signaling Network in Development and Disease  WP3878,0.6808707863293184,0.97509765625,0.37481070098713887,['KAT5'],0.9260978414502453,0,0,1
186,Cardiac Progenitor Differentiation WP2406,0.6808707863293184,0.97509765625,0.37481070098713887,['MESP1'],0.9260978414502453,0,0,1
187,Type 2 papillary renal cell carcinoma WP4241,0.6808707863293184,0.97509765625,0.37481070098713887,['ELOB'],0.9260978414502453,0,0,1
188,Urea cycle and metabolism of amino groups WP497,0.6808707863293184,0.97509765625,0.37481070098713887,['ODC1'],0.9260978414502453,0,0,1
189,DNA Mismatch Repair WP531,0.6808707863293184,0.97509765625,0.37481070098713887,['POLE3'],0.9260978414502453,0,0,1
190,Heart Development WP1591,0.6808707863293184,0.97509765625,0.37481070098713887,['VEGFB'],0.9260978414502453,0,0,1
191,IL-6 signaling pathway WP364,0.6808707863293184,0.97509765625,0.37481070098713887,['VIP'],0.9260978414502453,0,0,1
192,Imatinib and Chronic Myeloid Leukemia WP3640,0.6808707863293184,0.97509765625,0.37481070098713887,['GADD45A'],0.9260978414502453,0,0,1
193,Integrin-mediated Cell Adhesion WP185,0.6808707863293184,0.97509765625,0.37481070098713887,['HRAS'],0.9260978414502453,0,0,1
194,Joubert Syndrome WP4656,0.6808707863293184,0.97509765625,0.37481070098713887,['KAT5'],0.9260978414502453,0,0,1
195,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6808707863293184,0.97509765625,0.37481070098713887,['CYCS'],0.9260978414502453,0,0,1
196,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6808707863293184,0.97509765625,0.37481070098713887,['GSTP1'],0.9260978414502453,0,0,1
197,Pre-implantation embryo WP3527,0.6808707863293184,0.97509765625,0.37481070098713887,['DDIT3'],0.9260978414502453,0,0,1
198,Chemokine signaling pathway WP3929,0.6903017120773046,0.8662752772341813,0.32106458537102933,"['CXCL12', 'HRAS']",0.9260978414502453,0,0,2
199,Ebola Virus Pathway on Host WP4217,0.6903017120773046,0.8662752772341813,0.32106458537102933,"['HLA-B', 'CLEC4G']",0.9260978414502453,0,0,2
200,Endoderm differentiation WP2853,0.6903017120773046,0.8662752772341813,0.32106458537102933,"['TCEAL2', 'NME1']",0.9260978414502453,0,0,2
201,Oxidative Damage WP3941,0.6903017120773046,0.8662752772341813,0.32106458537102933,"['GADD45A', 'CYCS']",0.9260978414502453,0,0,2
202,Pancreatic adenocarcinoma pathway WP4263,0.6903017120773046,0.8662752772341813,0.32106458537102933,"['GADD45A', 'BAX']",0.9260978414502453,0,0,2
203,Small cell lung cancer WP4658,0.7055932582504736,0.834873949579832,0.29113417884923204,"['GADD45A', 'CYCS', 'BAX']",0.9404594390163877,0,0,3
204,Adipogenesis WP236,0.743361407372032,0.7788235294117647,0.2309779808558364,"['GADD45A', 'DDIT3', 'MIF']",0.9404594390163877,0,0,3
205,Alpha 6 Beta 4 signaling pathway WP244,0.7461209571532227,0.7796875,0.22834516864359863,['HRAS'],0.9404594390163877,0,0,1
206,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7461209571532227,0.7796875,0.22834516864359863,['HRAS'],0.9404594390163877,0,0,1
207,Aryl Hydrocarbon Receptor Netpath WP2586,0.7461209571532227,0.7796875,0.22834516864359863,['HRAS'],0.9404594390163877,0,0,1
208,ATM Signaling Pathway WP2516,0.7461209571532227,0.7796875,0.22834516864359863,['GADD45A'],0.9404594390163877,0,0,1
209,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7461209571532227,0.7796875,0.22834516864359863,['FADD'],0.9404594390163877,0,0,1
210,Common Pathways Underlying Drug Addiction WP2636,0.7461209571532227,0.7796875,0.22834516864359863,['PPP1CC'],0.9404594390163877,0,0,1
211,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7461209571532227,0.7796875,0.22834516864359863,['DDIT3'],0.9404594390163877,0,0,1
212,Integrated Cancer Pathway WP1971,0.7461209571532227,0.7796875,0.22834516864359863,['BAX'],0.9404594390163877,0,0,1
213,Nucleotide Excision Repair WP4753,0.7461209571532227,0.7796875,0.22834516864359863,['POLE3'],0.9404594390163877,0,0,1
214,Oxysterols derived from cholesterol WP4545,0.7461209571532227,0.7796875,0.22834516864359863,['ACOT11'],0.9404594390163877,0,0,1
215,Pathways affected in adenoid cystic carcinoma WP3651,0.7461209571532227,0.7796875,0.22834516864359863,['HRAS'],0.9404594390163877,0,0,1
216,Gastrin signaling pathway WP4659,0.7777809340380516,0.7080590642234478,0.17794258558193587,"['KAT5', 'HRAS']",0.9485600228008743,0,0,2
217,Regulation of Actin Cytoskeleton WP51,0.7777809340380516,0.7080590642234478,0.17794258558193587,"['CFL2', 'TMSB4X']",0.9485600228008743,0,0,2
218,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7980504988878204,0.6494140625,0.1464970333437018,['HRAS'],0.9485600228008743,0,0,1
219,TGF-beta Receptor Signaling WP560,0.7980504988878204,0.6494140625,0.1464970333437018,['HRAS'],0.9485600228008743,0,0,1
220,Type II interferon signaling (IFNG) WP619,0.7980504988878204,0.6494140625,0.1464970333437018,['HLA-B'],0.9485600228008743,0,0,1
221,DNA Replication WP466,0.7980504988878204,0.6494140625,0.1464970333437018,['UBA52'],0.9485600228008743,0,0,1
222,G13 Signaling Pathway WP524,0.7980504988878204,0.6494140625,0.1464970333437018,['CFL2'],0.9485600228008743,0,0,1
223,Galanin receptor pathway WP4970,0.7980504988878204,0.6494140625,0.1464970333437018,['VAMP2'],0.9485600228008743,0,0,1
224,Genes controlling nephrogenesis WP4823,0.7980504988878204,0.6494140625,0.1464970333437018,['CXCL12'],0.9485600228008743,0,0,1
225,IL-3 signaling pathway WP286,0.7980504988878204,0.6494140625,0.1464970333437018,['HRAS'],0.9485600228008743,0,0,1
226,Mesodermal commitment pathway WP2857,0.7980504988878204,0.6494140625,0.1464970333437018,['RPL38'],0.9485600228008743,0,0,1
227,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7980504988878204,0.6494140625,0.1464970333437018,['BAX'],0.9485600228008743,0,0,1
228,PPAR signaling pathway WP3942,0.7980504988878204,0.6494140625,0.1464970333437018,['FABP6'],0.9485600228008743,0,0,1
229,Cell cycle WP179,0.8072301543379474,0.6865051903114187,0.1470126521086704,"['GADD45A', 'CDC14A', 'ANAPC11']",0.9552810996750382,0,0,3
230,Aryl Hydrocarbon Receptor Pathway WP2873,0.839374545652432,0.5563616071428571,0.0974179454455907,['BAX'],0.9589889632168519,0,0,1
231,Bladder cancer WP2828,0.839374545652432,0.5563616071428571,0.0974179454455907,['HRAS'],0.9589889632168519,0,0,1
232,Thermogenesis WP4321,0.839374545652432,0.5563616071428571,0.0974179454455907,['HRAS'],0.9589889632168519,0,0,1
233,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.839374545652432,0.5563616071428571,0.0974179454455907,['HRAS'],0.9589889632168519,0,0,1
234,Toll-like Receptor Signaling Pathway WP75,0.839374545652432,0.5563616071428571,0.0974179454455907,['FADD'],0.9589889632168519,0,0,1
235,Fragile X Syndrome  WP4549,0.839374545652432,0.5563616071428571,0.0974179454455907,['AP2M1'],0.9589889632168519,0,0,1
236,Glycogen Synthesis and Degradation WP500,0.839374545652432,0.5563616071428571,0.0974179454455907,['CALM3'],0.9589889632168519,0,0,1
237,Prolactin Signaling Pathway WP2037,0.839374545652432,0.5563616071428571,0.0974179454455907,['HRAS'],0.9589889632168519,0,0,1
238,Allograft Rejection WP2328,0.8684351402524134,0.5554934302488118,0.07835922328029389,"['CXCL12', 'HLA-B']",0.9589889632168519,0,0,2
239,AMP-activated protein kinase (AMPK) signaling WP1403,0.8722556708682087,0.486572265625,0.06650114407705543,['HMGCR'],0.9589889632168519,0,0,1
240,ErbB signaling pathway WP673,0.8722556708682087,0.486572265625,0.06650114407705543,['HRAS'],0.9589889632168519,0,0,1
241,ESC Pluripotency Pathways WP3931,0.8722556708682087,0.486572265625,0.06650114407705543,['HRAS'],0.9589889632168519,0,0,1
242,G Protein Signaling Pathways WP35,0.8722556708682087,0.486572265625,0.06650114407705543,['HRAS'],0.9589889632168519,0,0,1
243,G1 to S cell cycle control WP45,0.8722556708682087,0.486572265625,0.06650114407705543,['GADD45A'],0.9589889632168519,0,0,1
244,Nephrotic syndrome WP4758,0.8722556708682087,0.486572265625,0.06650114407705543,['CUBN'],0.9589889632168519,0,0,1
245,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8722556708682087,0.486572265625,0.06650114407705543,['NDUFA13'],0.9589889632168519,0,0,1
246,Focal Adhesion WP306,0.8723426000111346,0.621139489194499,0.08483090974013903,"['PPP1CC', 'VEGFB', 'HRAS', 'MYL12B']",0.9589889632168519,0,0,4
247,Breast cancer pathway WP4262,0.8775987560065656,0.5826470588235294,0.07607377207971068,"['GADD45A', 'BAX', 'HRAS']",0.9589889632168519,0,0,3
248,NRF2 pathway WP2884,0.8775987560065656,0.5826470588235294,0.07607377207971068,"['PRDX1', 'GSTP1', 'MAFF']",0.9589889632168519,0,0,3
249,Calcium Regulation in the Cardiac Cell WP536,0.8953996996829748,0.5546218487394958,0.061277432991274944,"['RGS16', 'CALM3', 'CALR']",0.9623351003426147,0,0,3
250,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8984161637884926,0.4322916666666667,0.046307897757617095,['BEX3'],0.9623351003426147,0,0,1
251,Corticotropin-releasing hormone signaling pathway WP2355,0.8984161637884926,0.4322916666666667,0.046307897757617095,['CRH'],0.9623351003426147,0,0,1
252,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8984161637884926,0.4322916666666667,0.046307897757617095,['HMGCS1'],0.9623351003426147,0,0,1
253,Endochondral Ossification WP474,0.8984161637884926,0.4322916666666667,0.046307897757617095,['HMGCS1'],0.9623351003426147,0,0,1
254,T-cell receptor (TCR) signaling pathway WP69,0.9192275281357464,0.3888671875,0.032751018650511415,['HRAS'],0.963035654604021,0,0,1
255,Wnt signaling pathway and pluripotency WP399,0.9192275281357464,0.3888671875,0.032751018650511415,['LDLR'],0.963035654604021,0,0,1
256,Glioblastoma signaling pathways WP2261,0.9192275281357464,0.3888671875,0.032751018650511415,['HRAS'],0.963035654604021,0,0,1
257,Retinoblastoma gene in cancer WP2446,0.9192275281357464,0.3888671875,0.032751018650511415,['H2AFZ'],0.963035654604021,0,0,1
258,Metapathway biotransformation Phase I and II WP702,0.9239456464835625,0.45677449061816505,0.036131790932137045,"['GPX4', 'GSTP1']",0.963035654604021,0,0,2
259,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9239456464835625,0.45677449061816505,0.036131790932137045,"['PSMD8', 'STUB1']",0.963035654604021,0,0,2
260,Ras signaling WP4223,0.9239456464835625,0.45677449061816505,0.036131790932137045,"['CALM3', 'HRAS']",0.963035654604021,0,0,2
261,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9357818163128138,0.3533380681818182,0.02345208353958004,['HRAS'],0.9679269932090555,0,0,1
262,Regulation of toll-like receptor signaling pathway WP1449,0.9357818163128138,0.3533380681818182,0.02345208353958004,['FADD'],0.9679269932090555,0,0,1
263,Spinal Cord Injury WP2431,0.9477678902290964,0.4082809764136368,0.02190249764221222,"['GADD45A', 'MIF']",0.9741099928762142,0,0,2
264,B Cell Receptor Signaling Pathway WP23,0.9489484801450943,0.32373046875,0.01696372597027023,['HRAS'],0.9741099928762142,0,0,1
265,MAPK Signaling Pathway WP382,0.9725600819818923,0.4,0.011129369775862612,"['GADD45A', 'DDIT3', 'HRAS']",0.9945803102531804,0,0,3
266,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.979630698498873,0.2423095703125,0.004986638056840307,['HRAS'],0.9948333368797231,0,0,1
267,Vitamin D Receptor Pathway WP2877,0.9801494499885094,0.32240704500978473,0.006464331845463007,"['GADD45A', 'ZNF257']",0.9948333368797231,0,0,2
268,Nuclear Receptors Meta-Pathway WP2882,0.9937496165115354,0.34952670119664225,0.002191532036921011,"['PRDX1', 'GSTP1', 'MAFF', 'BAX']",0.9992431636253918,0,0,4
269,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9959347024161548,0.16796875,0.0006842347066487348,['VAMP2'],0.9992431636253918,0,0,1
270,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9973651537346544,0.2264302981466559,0.0005973963953339445,"['VEGFB', 'HRAS']",0.9992431636253918,0,0,2
271,PI3K-Akt signaling pathway WP4172,0.9992431636253918,0.19187866927592956,0.000145275738338141,"['VEGFB', 'HRAS']",0.9992431636253918,0,0,2
